Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

655
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
655
Stimulants01:29

Stimulants

311
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
311
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

241
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
241
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

294
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
294
Drug Dependence01:17

Drug Dependence

1.2K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.2K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

324
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
324

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-traumatic stress disorder in Australia: Results from the 2020-2022 National Study of Mental Health and Wellbeing.

The Australian and New Zealand journal of psychiatry·2026
Same author

Evaluating Co-Designed vs Researcher-Driven Personalized Feedback Formats in a Brief Digital Alcohol Use Intervention: Mixed Methods Study.

Journal of medical Internet research·2026
Same author

Perceived Barriers and Facilitators to Help-Seeking for Alcohol and Other Drug Use Among Australian Public Safety Personnel.

Drug and alcohol review·2026
Same author

Climate change and social health.

Nature human behaviour·2026
Same author

Behavior Change Techniques in Digital Health Interventions for Promoting Adolescent Health Behaviors: Systematic Umbrella Review.

JMIR mental health·2026
Same author

Prevalence, Associations and Comorbidity of Cannabis Use and Cannabis Use Disorders in the Australian National Mental Health Surveys From 2007 to 2020-22.

Drug and alcohol review·2026

Related Experiment Video

Updated: Sep 9, 2025

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

25.2K

Knowledge and Attitudes About Crystal Methamphetamine Among Key Community Groups in Australia.

Steph Kershaw1, Amelia Russell1, Louise Birrell1

  • 1The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, Australia.

Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals
|September 2, 2025
PubMed
Summary

Stigmatising attitudes towards crystal methamphetamine use are common in Australia, particularly among those who have not used the drug. Increased knowledge about crystal methamphetamine is linked to reduced stigma and discrimination.

Keywords:
attitudesdiscriminationknowledgemethamphetaminestigma

More Related Videos

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K

Related Experiment Videos

Last Updated: Sep 9, 2025

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

25.2K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K

Area of Science:

  • Public Health
  • Social Science
  • Addiction Studies

Background:

  • Crystal methamphetamine use presents a significant global health challenge, often accompanied by profound social stigma.
  • Addressing drug use as a public health concern necessitates understanding community perceptions and knowledge gaps.

Purpose of the Study:

  • To investigate knowledge and attitudes surrounding crystal methamphetamine use within diverse Australian community groups.
  • To identify factors influencing stigmatising attitudes and discrimination experienced by crystal methamphetamine users.

Main Methods:

  • A cross-sectional online survey was administered to 736 Australian residents aged 18+ (February-April 2022).
  • Data from 2022 was combined with a 2019 survey (n=2108) for comparative analysis.
  • Linear regression models were employed to examine predictors of knowledge and attitudes.

Main Results:

  • Stigmatising attitudes were prevalent, especially among individuals who had not used crystal methamphetamine.
  • Family/friends, community members, females, and regional respondents reported higher stigma scores.
  • Higher knowledge scores and recent survey participation (2022 vs. 2019) correlated with less stigmatising attitudes; health workers exhibited the highest knowledge.

Conclusions:

  • Prevalent stigma and discrimination against crystal methamphetamine users persist in Australia.
  • Targeted, evidence-based educational initiatives are crucial for reducing public and self-stigma.
  • Reducing stigma is essential to encourage help-seeking behaviours and improve health outcomes for individuals using crystal methamphetamine.